These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11489318)

  • 21. Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres.
    Choi SH; Park TG
    Int J Pharm; 2000 Aug; 203(1-2):193-202. PubMed ID: 10967441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres.
    Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
    J Control Release; 2019 Aug; 308():1-13. PubMed ID: 31301338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.
    Okada H; Doken Y; Ogawa Y; Toguchi H
    Pharm Res; 1994 Aug; 11(8):1143-7. PubMed ID: 7971715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant.
    Ravivarapu HB; Moyer KL; Dunn RL
    AAPS PharmSciTech; 2000 Feb; 1(1):E1. PubMed ID: 14727850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase-sensitive polymer-based controlled delivery systems of leuprolide acetate: in vitro release, biocompatibility, and in vivo absorption in rabbits.
    Singh S; Singh J
    Int J Pharm; 2007 Jan; 328(1):42-8. PubMed ID: 16959451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data.
    Crawford ED; Hafron JM; Tagawa ST; Twardowski PW; Harris RG; Moul JW; Keane TE; Concepcion RS; Higano CS; Gordan LN; Petrylak DP; Cross CK; Kader AK; Shore ND
    J Urol; 2021 Feb; 205(2):554-560. PubMed ID: 33090917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
    Doty AC; Hirota K; Olsen KF; Sakamoto N; Ackermann R; Feng MR; Wang Y; Choi S; Qu W; Schwendeman A; Schwendeman SP
    Biomaterials; 2016 Dec; 109():88-96. PubMed ID: 27693924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends.
    Jiang W; Schwendeman SP
    Pharm Res; 2001 Jun; 18(6):878-85. PubMed ID: 11474795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation.
    Guerrero S; Muñíz E; Teijón C; Olmo R; Teijón JM; Blanco MD
    J Pharm Sci; 2008 Aug; 97(8):3153-69. PubMed ID: 18023014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation.
    Hirota K; Doty AC; Ackermann R; Zhou J; Olsen KF; Feng MR; Wang Y; Choi S; Qu W; Schwendeman AS; Schwendeman SP
    J Control Release; 2016 Dec; 244(Pt B):302-313. PubMed ID: 27565212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
    Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterostereocomplexes prepared from d-poly(lactide) and leuprolide. I. Characterization.
    Slager J; Domb AJ
    Biomacromolecules; 2003; 4(5):1308-15. PubMed ID: 12959599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel approach for the intravenous delivery of leuprolide using core-cross-linked polymeric micelles.
    Hu Q; van Gaal EV; Brundel P; Ippel H; Hackeng T; Rijcken CJ; Storm G; Hennink WE; Prakash J
    J Control Release; 2015 May; 205():98-108. PubMed ID: 25583642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
    Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
    J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo release of naltrexone from biodegradable depot systems.
    Liu Y; Sunderland VB; O'Neil AG
    Drug Dev Ind Pharm; 2006 Jan; 32(1):85-94. PubMed ID: 16455607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
    Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
    J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs.
    Okada H; Doken Y; Ogawa Y; Toguchi H
    Pharm Res; 1994 Aug; 11(8):1199-203. PubMed ID: 7971724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion.
    Zheng JY; Fulu MY
    Int J Pharm; 2006 Jan; 307(2):209-15. PubMed ID: 16300912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.